TYPE C HEPATITIS VIRUS INHIBITOR

Title:

TYPE C HEPATITIS VIRUS INHIBITOR

Document Type and Number:

Japanese Patent JP2014205694

Kind Code:

A

Abstract:

PROBLEM TO BE SOLVED: To provide a compound having ability for inhibiting HCV.SOLUTION: There is provided a compound represented by the formula (1-I) or a pharmaceutically acceptable salt thereof. In the formula (1-I), D and Z are each independently null or an optionally substituted linear aliphatic group containing C0 to 8, A and E are each independently null or a specific cyclic group, T is null or a specific aliphatic group, 0 to 4 of A, D, E, T and Z exist, a ring B is a specific 5-member heteroaryl, Ris independently H, halogen, cyano, optically substituted C1 to 4 alkyl and the like, u is independently 1, 2 or 3, Q and J are each independently a specific nitrogen-containing group.

More Like This:

WO/2017/028816	INDOLE DERIVATIVE, PREPARATION METHOD THEREOF, AND USE THEREOF IN PHARMACEUTICAL DRUG
JP6412968	Methods and compositions for regulating IRE1, SRC, and ABL activity
WO/2003/020684	(ALPHA)-HALOENAMINE REAGENTS

Inventors:

QIU YAO-LING
WANG CE
PENG XIAOWEN
YING LU
OR YAT SUN

Application Number:

JP2014121521A

Publication Date:

October 30, 2014

Filing Date:

June 12, 2014

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ENANTA PHARM INC

International Classes:

C07D403/14; A61K31/4184; A61K31/4196; A61K31/422; A61K31/437; A61P1/16; A61P31/14; C07D409/14; C07D413/14; C07D471/04

Attorney, Agent or Firm:

Yoshinori Hosoda

Previous Patent: COMPOSITIONS AND METHODS FOR MODULATING CELLULAR MEMBRANE-MEDIATED INTRACELLULAR SIGNAL TRANSDUCTION

Next Patent: AZAADAMANTANE ESTER AND CARBAMATE DERIVATIVES, AND METHODS OF USE THEREOF